# South Korea Isotretinoin Drugs Market > South Korea Isotretinoin Drugs Market Research Report By Form (Capsules, Injection) andBy Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.72% - **2024:** $ 32.5 Million - **2025:** $ 34.03 Million - **2035:** $ 54 Million - **Key Players:** Roche (CH), Mylan (US), Teva (IL), Sandoz (DE), Sun Pharmaceutical Industries (IN), Hikma Pharmaceuticals (GB), Aurobindo Pharma (IN), Lupin Pharmaceuticals (IN) **Report ID:** MRFR/Pharma/47758-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-isotretinoin-drugs-market-49509 --- ## Market Summary ## **South Korea Isotretinoin Drugs Market Overview** As per MRFR analysis, the South Korea Isotretinoin Drugs Market Size was estimated at 31.25 (USD Million) in 2023. The South Korea Isotretinoin Drugs Market Industry is expected to grow from 32.5(USD Million) in 2024 to 67 (USD Million) by 2035. The South Korea Isotretinoin Drugs Market CAGR (growth rate) is expected to be around 6.798% during the forecast period (2025 - 2035). ### **Key South Korea Isotretinoin Drugs Market Trends Highlighted** The South Korea Isotretinoin Drugs Market is experiencing several important trends driven by the increasing prevalence of acne and a growing awareness of dermatological health among the population. The rising incidence of severe acne conditions has led to a greater demand for isotretinoin treatments. Additionally, the South Korean government's initiatives to improve healthcare access and the emphasis on mental health linked to skin conditions have further propelled the market. As more individuals seek effective solutions for acne, the popularity of isotretinoin as a reliable treatment option continues to rise. Opportunities in the South Korea isotretinoin drugs market are emerging from advancements in drug formulations and increased availability of generic options. At present, pharmaceutical companies are concentrating on creating new delivery systems that maximize isotretinoin effectiveness while minimizing side effects. Furthermore, marketing campaigns highlighting the advantages of effective acne treatment will likely target newer consumers, potentially creating new market opportunities. Recently, there have been trends indicating a rise in interest in telemedicine and virtual consultations related to dermatology. A number of patients are now using virtual clinics to obtain prescriptions for isotretinoin, which vastly improves convenience. This trend coincides with the more generalized shift toward digital healthcare in South Korea, which is characterized by increasing the use of technology in the provision of medical services. Furthermore, there is a notable emphasis on personalized medicine approaches, where treatments are tailored to individual patient needs, enhancing the patient experience in managing acne conditions. Overall, these trends indicate a robust growth trajectory for isotretinoin drugs in the South Korean market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **South Korea Isotretinoin Drugs Market Drivers** Increasing Prevalence of Acne among Adolescents and Young Adults The rising prevalence of acne in South Korea, particularly among adolescents and young adults, is significantly driving the South Korea Isotretinoin Drugs Market Industry. According to a national health survey conducted by the Korean Society of Dermatology, approximately 45% of teenagers experience some form of acne, with nearly 20% classified as severe cases requiring medical treatment. As lifestyles and dietary habits change, the incidence of acne continues to rise, leading to increased demand for effective treatments like isotretinoin.This growing patient demographic is prompting healthcare providers and pharmaceutical companies to focus on developing and marketing isotretinoin products. The South Korean healthcare system's focus on providing advanced dermatological care, supported by organizations like the Korean Dermatological Association, is also instrumental in addressing this emerging healthcare need. Growing Awareness of Dermatological Health and Treatment Options There is a marked increase in awareness regarding dermatological health in South Korea, contributing to the growth of the South Korea Isotretinoin Drugs Market Industry. Recent reports from the Ministry of Health and Welfare noted a 30% increase in public health campaigns focused on skin health and acne management over the past five years. As the public becomes more informed about treatment options, including isotretinoin, this has led to a higher consultation rate with dermatologists, thereby driving up the demand for isotretinoin prescriptions.Furthermore, with younger demographics actively engaging in skincare and health discussions on social media platforms, this trend is bolstering the growth of the market. Government Initiatives Supporting Mental Health and Acne Treatment The South Korean government has implemented several initiatives aimed at improving mental health, which have indirect benefits for the South Korea Isotretinoin Drugs Market Industry. With acne often leading to significant psychological impacts, including low self-esteem and depression, initiatives highlighted by the Mental Health Centre of South Korea show a correlation between effective acne treatment and enhanced mental health outcomes. In recent years, the government emphasized the importance of treating acne as part of an overall mental health strategy, leading to an increased focus on dermatological treatments such as isotretinoin.As the government promotes awareness and access to effective treatments, demand for isotretinoin is likely to rise. ## **South Korea Isotretinoin Drugs Market Segment Insights** ### **Isotretinoin Drugs Market Form Insights** The South Korea Isotretinoin Drugs Market has seen significant developments, particularly within the Form segment, which includes Capsules and Injection as its two primary formats. This segment plays a critical role in delivering isotretinoin to patients suffering from severe acne and other related dermatological conditions, with a clear preference for Forms that offer ease of administration and effectiveness. Capsules are notably favored due to their oral consumption convenience and established efficacy; they provide a controlled dosage that is pivotal for treatment adherence, particularly for chronic conditions. On the other hand, Injection formats may appeal to a niche market segment that requires rapid action or specific therapeutic intervention, thus providing healthcare professionals the flexibility to tailor treatment plans based on patient needs.  The pharmaceutical landscape in South Korea is bolstered by a regulatory environment that emphasizes safety and efficacy, allowing for rigorous testing and approval of new isotretinoin products. This focus on quality assurance supports the growth of both Capsules and Injection, as healthcare providers and patients alike seek trusted solutions for complex health issues. Additionally, the rise in awareness about skin disorders and the increasing prevalence of acne-related treatments in South Korea contribute to the growing demand within this Form segment. Moreover, ongoing technological advancements in drug formulation are enhancing the appeal of these Forms; manufacturers are investing in Research and Development to create improved delivery systems that minimize side effects and increase the bioavailability of isotretinoin. The opportunity for innovation in formulating these products continues to drive market dynamics as healthcare providers seek to offer their patients the best possible treatment outcomes.  At the same time, both Capsules and Injection play integral roles in the South Korea Isotretinoin Drugs Market; the preference for one over the other can significantly influence market trends, consumer behavior, and overall market revenue. This evolution reflects broader trends in support of personalized medicine and points towards a future where Form options could become increasingly sophisticated to meet diverse medical needs. As the South Korea Isotretinoin Drugs Market navigates toward greater growth, the dynamics within the Form segment will continue to shape the competitive landscape, presenting both challenges and opportunities for pharmaceutical companies. The ongoing discussions around patient-centered care further underline the importance of offering versatile delivery methods designed to enhance patient adherence and satisfaction, ultimately driving advancements in the South Korean pharmaceutical industry at large. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Isotretinoin Drugs Market Distribution Channel Insights** In the South Korea Isotretinoin Drugs Market, the Distribution Channel plays a critical role in the accessibility and availability of these medications. Hospitals pharmacies are significant as they not only cater to inpatients but also provide specialized services in dermatology, ensuring that patients receive tailored treatments based on their specific needs. Retail pharmacies are also vital as they serve as the primary point of access for patients seeking isotretinoin, leveraging their widespread availability and established trust with customers. The growing trend toward online pharmacies reflects the increasing demand for convenience, allowing patients to access isotretinoin without the need for physical visits, which is especially relevant given South Korea's tech-savvy population. This segment is continuously evolving, driven by changing consumer behavior, technological advancements, and increased health awareness, with notable opportunities for growth as e-commerce platforms gain popularity. Furthermore, the regulatory environment in South Korea supports the safe distribution of pharmaceuticals, enhancing the efficiency of these channels and ensuring that isotretinoin drugs are safely delivered to those in need while catering to the unique demands of each channel. ## **South Korea Isotretinoin Drugs Market Key Players and Competitive Insights** The South Korea Isotretinoin Drugs Market exhibits a competitive landscape characterized by a blend of domestic and international pharmaceutical companies striving to capture the rising demand for effective acne treatments. Isotretinoin, known for its efficacy in treating severe acne, has seen increased popularity due to the growing awareness of skin health and the significant impact of acne on the quality of life. The market is propelled by the introduction of more potent formulations, marketing strategies that resonate with healthcare professionals and patients, and a regulatory environment that is becoming more conducive to innovation. Companies are continuously engaged in research and development to improve drug efficacy and safety profiles, ensuring they remain competitive in this lucrative sector.Teva Pharmaceutical Industries stands out in the South Korea Isotretinoin Drugs Market due to its robust product portfolio and established brand reputation.  The company's position is reinforced by years of experience in developing generics and brand medications widely recognized for their efficacy and safety. In South Korea, Teva leverages its strengths in extensive research and development capabilities, enabling it to offer high-quality formulations that meet local regulatory requirements. Teva's strategic alliances and collaborations with healthcare professionals help in building trust with both patients and prescribers. Its strong distribution network allows effective market penetration, ensuring that its isotretinoin products reach a wide array of healthcare facilities across the region.Fougera Pharmaceuticals has carved a niche in the South Korea Isotretinoin Drugs Market with its focused approach to dermatological products. The company specializes in the development and distribution of high-quality dermatological medications and is known for its commitment to safety and patient care.  Its key products include various isotretinoin formulations designed to cater to different patient needs, strengthening its presence in the competitive landscape. Fougera often engages in strategic partnerships and collaborations to enhance its market position and expand its product offerings. The company's strengths lie in its ability to innovate within its product lines, providing effective solutions for severe acne while also implementing targeted marketing campaigns to increase brand awareness in South Korea. Through these efforts and its commitment to quality, Fougera Pharmaceuticals continues to maintain its competitive edge in this dynamic market. **Key Companies in the South Korea Isotretinoin Drugs Market Include** ## **South Korea Isotretinoin Drugs Market Industry Developments** Recent developments in the South Korea Isotretinoin Drugs Market highlight a growing interest among leading pharmaceutical companies. Merck announced a strategic initiative in July 2023 aimed at expanding its dermatology portfolio, which includes Isotretinoin products, reflecting the market's potential. Likewise, Teva Pharmaceutical Industries and Aurobindo Pharma have recently ramped up their production capacities in South Korea due to a surge in demand for acne treatments driven by an increasing prevalence of skin conditions among the youth population. In terms of market valuation, it was reported in early 2023 that the South Korean Isotretinoin market is expected to experience steady growth, attributed to advancements in formulations and rising consumer awareness regarding skin health. Furthermore, collaborative research efforts between industry players such as Cipla and Almirall are focused on enhancing the efficacy and safety profiles of Isotretinoin formulations, tailoring them for better patient compliance. There have been no significant acquisitions or mergers reported in this niche market segment among the specified companies in recent months, reflecting an ongoing period of consolidation and focus on organic growth strategies among key players. ## **South Korea Isotretinoin Drugs Market Segmentation Insights** ### **Isotretinoin Drugs Market Form****Outlook** ### **Isotretinoin Drugs Market Distribution Channel****Outlook** ## Market Drivers ### Growing Awareness of Skin Health There is a notable increase in public awareness regarding skin health in South Korea, which is driving the isotretinoin drugs market. Educational campaigns and social media influence have contributed to a heightened understanding of acne and its psychological impacts. As individuals become more informed about treatment options, the demand for isotretinoin is likely to rise. This awareness is particularly pronounced among younger demographics, who are more active in seeking solutions for their skin concerns. The isotretinoin drugs market may experience a surge in demand as more individuals recognize the importance of addressing acne effectively, leading to increased consultations with dermatologists. ### Regulatory Support for Acne Treatments Regulatory bodies in South Korea are increasingly supportive of innovative treatments for acne, which positively impacts the isotretinoin drugs market. Streamlined approval processes for new formulations and generics are facilitating quicker access to isotretinoin products. This regulatory environment encourages pharmaceutical companies to invest in research and development, potentially leading to a wider array of isotretinoin options for consumers. As a result, the isotretinoin drugs market is likely to expand, with more products available to meet the diverse needs of patients. The supportive regulatory framework may also enhance patient safety and treatment efficacy, further driving market growth. ### Advancements in Dermatological Research Ongoing advancements in dermatological research are significantly influencing the isotretinoin drugs market. Researchers are continuously exploring the mechanisms of acne formation and the role of isotretinoin in managing severe cases. This research is leading to improved treatment protocols and a better understanding of the drug's long-term effects. As new findings emerge, healthcare professionals are more likely to prescribe isotretinoin, thereby expanding its market reach. Furthermore, the introduction of new formulations and delivery methods may enhance patient compliance and satisfaction, potentially increasing the market size. The isotretinoin drugs market is expected to see a notable increase in adoption rates as these advancements become integrated into clinical practice. ### Increasing Prevalence of Acne Disorders The rising incidence of acne disorders in South Korea is a primary driver for the isotretinoin drugs market. Recent studies indicate that approximately 30% of adolescents and young adults experience moderate to severe acne, leading to a growing demand for effective treatment options. This trend is further exacerbated by the societal pressures related to appearance, prompting individuals to seek medical intervention. The isotretinoin drugs market is likely to benefit from this increasing prevalence, as healthcare providers recommend isotretinoin for its efficacy in treating severe cases. Moreover, the market is projected to grow at a CAGR of around 5% over the next few years, reflecting the heightened need for effective acne solutions in the region. ### Rising Disposable Income and Healthcare Spending The increase in disposable income and healthcare spending in South Korea is a significant driver for the isotretinoin drugs market. As individuals have more financial resources, they are more inclined to invest in healthcare services and effective treatments for acne. This trend is particularly evident among the middle and upper classes, who prioritize skin health and are willing to pay for advanced therapies. The isotretinoin drugs market is expected to benefit from this economic shift, as higher spending on healthcare correlates with increased demand for prescription medications. Consequently, the market may witness a robust growth trajectory as more consumers seek effective solutions for their acne-related concerns. ## Future Outlook The [Isotretinoin Drugs Market](https://www.marketresearchfuture.com/reports/isotretinoin-drugs-market-3560) is projected to grow at a 4.72% CAGR from 2025 to 2035, driven by increasing acne prevalence and advancements in drug formulations. **New opportunities:** - Development of personalized isotretinoin treatment plans - Expansion of telehealth services for isotretinoin prescriptions - Investment in patient education programs to enhance adherence By 2035, the isotretinoin drugs market is expected to achieve robust growth and increased accessibility. ## Segment Insights ### By Form: Capsules (Largest) vs. Injections (Fastest-Growing) In the South Korea isotretinoin drugs market, the form segment is primarily dominated by capsules, which hold the largest market share due to their ease of administration and patient preference. Capsules are widely recognized for their stability and dosage accuracy, making them a conventional choice among healthcare providers. In contrast, injections are emerging as the fastest-growing segment, driven by their effective delivery method and rapid onset of action, appealing to a specific patient demographic. The growth trends for these segments showcase a diverse landscape in the South Korea isotretinoin drugs market. Capsules are expected to maintain their dominance; however, the increasing demand for injections, particularly in hospital settings, is notable. Factors such as the rising incidence of severe acne and the improvement in treatment protocols are propelling the growth of the injection segment. Moreover, advancements in injectable formulation technology are paving the way for enhanced therapeutic options, thereby attracting more practitioners to consider injections as viable treatment modalities. Capsules (Dominant) vs. Injections (Emerging) Capsules serve as the dominant form in the South Korea isotretinoin drugs market due to their established presence and patient familiarity, ensuring compliance and ease of use. Their formulation allows for controlled release, making them suitable for long-term treatment regimens. In contrast, injections represent an emerging segment, gaining traction among medical professionals for their effectiveness in rapidly addressing severe acne conditions. While the injection segment is still developing, its growth is spurred by innovations that simplify administration and enhance patient outcomes. As healthcare shifts toward more effective treatment approaches, both forms are expected to contribute significantly to the evolving therapeutic landscape. ### By Distribution Channel: Retail Pharmacies (Largest) vs. Online Pharmacies (Fastest-Growing) In the South Korea isotretinoin drugs market, the distribution channels are primarily divided into three categories: Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies. Among these, Retail Pharmacies hold the largest market share, benefiting from their widespread presence and continuous consumer trust. Hospitals Pharmacies also play a significant role, primarily serving patients under clinical supervision, while Online Pharmacies are emerging as a competitive channel due to increased consumer convenience and the push towards digital health solutions. The growth trends in the distribution channel segment reveal exciting dynamics. Retail Pharmacies are expected to maintain their dominance due to established networks and brand loyalty among consumers. Conversely, Online Pharmacies are rapidly growing, driven by changing consumer preferences for online shopping and the accessibility provided by digital platforms. Enhanced telemedicine services and government support for online pharmaceutical sales are further propelling this growth, making the segment increasingly competitive. Retail Pharmacies (Dominant) vs. Online Pharmacies (Emerging) In the South Korea isotretinoin drugs market, Retail Pharmacies are the dominant distribution channel, characterized by their extensive physical presence and strong relationships with healthcare providers. They offer a wide range of isotretinoin products and provide personal consultations, which strengthen customer loyalty and trust. In contrast, Online Pharmacies have emerged as a progressive alternative, appealing to tech-savvy consumers seeking convenience and discretion. With the rise of e-commerce, Online Pharmacies are not only expanding their offerings but also adopting digital marketing strategies to reach younger demographics. This comparative growth highlights the shift in consumer purchasing behavior, where the ease of online access is projected to drive increased market share for Online Pharmacies in the coming years. ## Competitive Benchmarking The isotretinoin drugs market in South Korea is characterized by a competitive landscape that is increasingly shaped by innovation, regulatory compliance, and strategic partnerships. Key players such as Roche (CH), Mylan (US), and Teva (IL) are actively engaged in enhancing their market presence through various strategic initiatives. Roche (CH) focuses on innovation and research, aiming to develop advanced formulations that improve patient outcomes. Mylan (US) emphasizes affordability and accessibility, leveraging its extensive distribution network to reach a broader patient base. Teva (IL) is concentrating on expanding its biosimilar portfolio, which may provide a competitive edge in the evolving market dynamics. Collectively, these strategies indicate a shift towards a more collaborative and innovation-driven environment, where companies are not only competing on price but also on the quality and efficacy of their products.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing their supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is significant, as they set industry standards and drive innovation. This competitive structure suggests that while there is room for smaller players, the dominance of established firms is likely to shape market trends and consumer preferences. In October Roche (CH) announced a partnership with a local South Korean biotech firm to co-develop a new isotretinoin formulation aimed at reducing side effects. This collaboration is strategically important as it not only enhances Roche's product offerings but also allows for localized expertise in addressing specific patient needs in South Korea. Such partnerships may facilitate faster regulatory approvals and market entry, thereby strengthening Roche's competitive position. In September Mylan (US) launched a new pricing strategy that includes tiered pricing for its isotretinoin products, aimed at making treatments more accessible to patients across different income levels. This move is significant as it reflects Mylan's commitment to affordability, potentially increasing its market share in a price-sensitive segment. By addressing the financial barriers to access, Mylan may enhance its brand loyalty and patient adherence to treatment regimens. In August Teva (IL) expanded its production capabilities in South Korea by investing in a new manufacturing facility dedicated to isotretinoin. This investment is likely to bolster Teva's supply chain reliability and reduce lead times for product availability. Furthermore, it positions Teva to respond more effectively to local market demands, which could enhance its competitive advantage in the region. As of November current trends in the isotretinoin drugs market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in drug development and patient management. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in navigating regulatory complexities and enhancing product offerings. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may redefine how companies position themselves in the market, emphasizing the importance of quality and patient-centric solutions. ## Recent News & Developments Recent developments in the South Korea Isotretinoin Drugs Market highlight a growing interest among leading pharmaceutical companies. Merck announced a strategic initiative in July 2023 aimed at expanding its dermatology portfolio, which includes Isotretinoin products, reflecting the market's potential. Likewise, Teva Pharmaceutical Industries and Aurobindo Pharma have recently ramped up their production capacities in South Korea due to a surge in demand for acne treatments driven by an increasing prevalence of skin conditions among the youth population. In terms of market valuation, it was reported in early 2023 that the South Korean Isotretinoin market is expected to experience steady growth, attributed to advancements in formulations and rising consumer awareness regarding skin health. Furthermore, collaborative research efforts between industry players such as Cipla and Almirall are focused on enhancing the efficacy and safety profiles of Isotretinoin formulations, tailoring them for better patient compliance. There have been no significant acquisitions or mergers reported in this niche market segment among the specified companies in recent months, reflecting an ongoing period of consolidation and focus on organic growth strategies among key players. ## Report Scope | MARKET SIZE 2024 | 32.5(USD Million) | | --- | --- | | MARKET SIZE 2025 | 34.03(USD Million) | | MARKET SIZE 2035 | 54.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.72% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Roche (CH), Mylan (US), Teva (IL), Sandoz (DE), Sun Pharmaceutical Industries (IN), Hikma Pharmaceuticals (GB), Aurobindo Pharma (IN), Lupin Pharmaceuticals (IN) | | Segments Covered | Form, Distribution Channel | | Key Market Opportunities | Emerging regulatory frameworks may enhance access to isotretinoin drugs in South Korea's evolving healthcare landscape. | | Key Market Dynamics | Rising demand for isotretinoin in South Korea driven by increasing acne prevalence and evolving treatment protocols. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What was the market valuation of isotretinoin drugs in South Korea in 2024?** A: The market valuation of isotretinoin drugs in South Korea was $32.5 Million in 2024. **Q: What is the projected market valuation for isotretinoin drugs in South Korea by 2035?** A: The projected market valuation for isotretinoin drugs in South Korea is $54.0 Million by 2035. **Q: What is the expected CAGR for the isotretinoin drugs market in South Korea from 2025 to 2035?** A: The expected CAGR for the isotretinoin drugs market in South Korea during the forecast period 2025 - 2035 is 4.72%. **Q: Which companies are the key players in the South Korean isotretinoin drugs market?** A: Key players in the South Korean isotretinoin drugs market include Roche (CH), Mylan (US), Teva (IL), Sandoz (DE), Sun Pharmaceutical Industries (IN), Hikma Pharmaceuticals (GB), Aurobindo Pharma (IN), and Lupin Pharmaceuticals (IN). **Q: What are the main segments of the isotretinoin drugs market in South Korea?** A: The main segments of the isotretinoin drugs market in South Korea are Form and Distribution Channel. **Q: What was the market value of isotretinoin capsules in South Korea in 2024?** A: The market value of isotretinoin capsules in South Korea was $20.0 Million in 2024. **Q: What is the projected market value for isotretinoin injections in South Korea by 2035?** A: The projected market value for isotretinoin injections in South Korea is $22.0 Million by 2035. **Q: How do retail pharmacies compare to online pharmacies in the isotretinoin drugs market in South Korea?** A: In 2024, retail pharmacies had a market value of $12.0 Million, while online pharmacies had a value of $10.5 Million. **Q: What is the expected market value for hospitals pharmacies in the isotretinoin drugs market by 2035?** A: The expected market value for hospitals pharmacies in the isotretinoin drugs market in South Korea is $16.0 Million by 2035. **Q: What trends are anticipated in the South Korean isotretinoin drugs market over the next decade?** A: Trends in the South Korean isotretinoin drugs market suggest a steady growth trajectory, with an anticipated increase in market valuation driven by a CAGR of 4.72% from 2025 to 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-isotretinoin-drugs-market-49509*